¼¼°èÀÇ Áö·ç¼º °¢È­Áõ Ä¡·á ½ÃÀå
Seborrheic Keratosis Treatment
»óǰÄÚµå : 1536209
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2024³â 08¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 192 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,260,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,780,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

¼¼°èÀÇ Áö·ç¼º °¢È­Áõ Ä¡·á ½ÃÀåÀº 2030³â±îÁö 33¾ï ´Þ·¯¿¡ ´ÞÇÒ Àü¸Á

2023³â¿¡ 23¾ï ´Þ·¯·Î ÃßÁ¤µÇ´Â ¼¼°èÀÇ Áö·ç¼º °¢È­Áõ Ä¡·á ½ÃÀåÀº ºÐ¼® ±â°£ÀÎ 2023-2030³â¿¡ CAGR 5.2%·Î ¼ºÀåÇϸç, 2030³â¿¡´Â 33¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. º» ¸®Æ÷Æ®¿¡¼­ ºÐ¼®ÇÑ ºÎ¹®ÀÇ ÇϳªÀÎ ³Ãµ¿¿ä¹ý ¾ÖÇø®ÄÉÀ̼ÇÀº CAGR 6.2%¸¦ ±â·ÏÇϸç, ºÐ¼® ±â°£ Á¾·á±îÁö 20¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. Àü±â ¸Þ½º ¿ëµµÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£¿¡ CAGR 4.0%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 6¾ï 3,560¸¸ ´Þ·¯·Î ÃßÁ¤, Áß±¹Àº CAGR 8.7%·Î ¼ºÀå ¿¹Ãø

¹Ì±¹ÀÇ Áö·ç¼º °¢È­Áõ Ä¡·á ½ÃÀåÀº 2023³â¿¡ 6¾ï 3,560¸¸ ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ÀÇ °æÁ¦´ë±¹ÀÎ Áß±¹Àº 2023-2030³âÀÇ ºÐ¼® ±â°£¿¡ CAGR 8.7%·Î ÃßÀÌÇϸç, 2030³â±îÁö 7¾ï 180¸¸ ´Þ·¯ÀÇ ½ÃÀå ±Ô¸ð¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ±âŸ ÁÖ¸ñÇØ¾ß ÇÒ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, ºÐ¼® ±â°£ Áß CAGRÀº °¢°¢ 2.0%¿Í 5.4%·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR 3.2%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¼¼°èÀÇ Áö·ç¼º °¢È­Áõ Ä¡·á ½ÃÀå - ÁÖ¿ä ÃËÁø¿äÀΰú µ¿Çâ Á¤¸®

Áö·ç¼º °¢È­ÁõÀº ÈçÇÑ ºñ¾Ï¼º ÇǺΠÁõ½ÄÁõÀ¸·Î º¸Åë ¾ó±¼, °¡½¿, ¾î±ú, µî¿¡ °¥»ö, °ËÀº»ö ¶Ç´Â ¿¶Àº °¥»öÀÇ Áõ½ÄÀ¸·Î ³ªÅ¸³³´Ï´Ù. ÀÌ·¯ÇÑ Áõ½ÄÀº ÀϹÝÀûÀ¸·Î ÅëÁõÀÌ ¾ø°í, ¿°ÁõÀ» ÀÏÀ¸Å°°Å³ª ¹Ì¿ë»óÀÇ ÀÌÀ¯°¡ ¾ø´Â ÇÑ Ä¡·á°¡ ÇÊ¿äÇÏÁö ¾Ê½À´Ï´Ù. Áö·ç¼º °¢È­Áõ Ä¡·á¿¡´Â ³Ãµ¿ ¿ä¹ý, ¼ÒÆÄ¼ú, Àü±â¿Ü°ú, ·¹ÀÌÀú Ä¡·á µîÀÌ ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¹æ¹ýÀº Áõ½ÄµÈ °¢ÁúÀ» Á¦°ÅÇϰųª ´«¿¡ ¶çÁö ¾Ê°Ô ÇÏ¿© Áõ»óÀ» ¿ÏÈ­Çϰí ȯÀÚÀÇ ÇǺΠ¹Ì°üÀ» °³¼±ÇÏ´Â °ÍÀ» ¸ñÇ¥·Î ÇÕ´Ï´Ù. Ä¡·á ¹æ¹ýÀÇ ¼±ÅÃÀº Áõ½ÄÀÇ Å©±â, ¼ö, À§Ä¡, ȯÀÚÀÇ Èñ¸Á°ú ÀÇ·áÁøÀÇ Ãßõ¿¡ µû¶ó °áÁ¤µË´Ï´Ù.

ÀÇ·á ºÐ¾ßÀÇ ±â¼ú ¹ßÀüÀº Áö·ç¼º °¢È­Áõ Ä¡·á ½ÃÀå¿¡ Å« ¿µÇâÀ» ¹ÌÄ¡°í ÀÖ½À´Ï´Ù. ¾×ü Áú¼Ò·Î ¼ºÀåÀ» µ¿°á½ÃŰ´Â ³Ãµ¿ ¿ä¹ýÀº ±× È¿°ú¿Í ÃÖ¼ÒÇÑÀÇ È¸º¹ ½Ã°£À¸·Î ÀÎÇØ ³Î¸® »ç¿ëµÇ´Â ±â¼úÀÔ´Ï´Ù. ¼ÒÆÄ¼úÀº ±¹¼Ò ¸¶Ãë ÇÏ¿¡ ¼ºÀå ºÎÀ§¸¦ ±Ü¾î³»´Â °ÍÀ¸·Î, Àü·ù¸¦ Èê·Á ¼ºÀå ºÎÀ§¸¦ ÆÄ±«ÇÏ´Â Àü±â¿Ü°ú°ú ÇÔ²² »ç¿ëµÇ´Â °æ¿ì°¡ ¸¹½À´Ï´Ù. ·¹ÀÌÀú Ä¡·á´Â Áý±¤µÈ ºûÀ» Á¶»çÇÏ¿© ¼ºÀåÀ» °Ü³ÉÇÏ¿© Á¦°ÅÇÏ´Â °ÍÀ¸·Î, Á¤È®µµ°¡ ³ô°í ÈäÅͰ¡ Àû´Ù´Â ÀåÁ¡À¸·Î Àα⸦ ¾ò°í ÀÖ½À´Ï´Ù. ºÐ¼ö ·¹ÀÌÀú¿Í °°Àº »õ·Î¿î ·¹ÀÌÀú ±â¼úÀÇ °³¹ß·Î Ä¡·á °á°ú°¡ °³¼±µÇ¾î Ä¡·á °úÁ¤ÀÌ ´õ ºü¸£°í ÅëÁõÀÌ Àû½À´Ï´Ù. ¶ÇÇÑ Áý¿¡¼­ ÇÒ ¼ö ÀÖ´Â ¿Ü¿ë Ä¡·áÀÇ ÃâÇöÀº ´õ ÀÛÀº ¼ºÀåÀ» °ü¸®ÇÒ ¼ö ÀÖ´Â ºñħ½ÀÀû ¿É¼ÇÀ» Á¦°øÇÏ¿© ȯÀÚ°¡ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¼±ÅÃÀÇ ÆøÀ» ³ÐÇôÁÖ°í ÀÖ½À´Ï´Ù.

Áö·ç¼º °¢È­Áõ Ä¡·á ½ÃÀåÀÇ ¼ºÀåÀº ¸î °¡Áö ¿äÀο¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù. ÇǺΠ°Ç°­¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö°í ÷´Ü ÇǺΰú Ä¡·á°¡ °¡´ÉÇØÁü¿¡ µû¶ó ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. Áö·ç¼º °¢È­Áõ¿¡ Ãë¾àÇÑ Àα¸ÀÇ °í·ÉÈ­´Â ½ÃÀå ¼ºÀå¿¡ Å©°Ô ±â¿©Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ °¡Ã³ºÐ ¼Òµæ Áõ°¡·Î ÀÎÇØ ¹Ì¿ë¼ºÇüÀ» ¼±ÅÃÇÏ´Â °³ÀÎÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. º¸´Ù È¿°úÀûÀÌ°í ´ú ħ½ÀÀûÀÎ Ä¡·á¹ýÀÇ °³¹ß µî ±â¼ú ¹ßÀüµµ ½ÃÀåÀ» ¹ßÀü½Ã۰í ÀÖ½À´Ï´Ù. ¼ÒºñÀÚ µ¿ÇâÀº º¸´Ù Æí¸®Çϰí ȸº¹ ½Ã°£ÀÌ ÂªÀº ºñħ½ÀÀû ¿Ü·¡ ȯÀÚ ½Ã¼ú¿¡ ´ëÇÑ ¼±È£µµ°¡ ³ô¾ÆÁö°í ÀÖÀ½À» º¸¿©ÁÝ´Ï´Ù. ÇǺΰú Ŭ¸®´ÐÀÇ È®´ë¿Í ¼÷·ÃµÈ ÇǺΰú Àü¹®ÀÇ Áõ°¡´Â ½ÃÀå ¼ºÀåÀ» ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ÀÌ ºÐ¾ßÀÇ Áö¼ÓÀûÀÎ ¿¬±¸°³¹ß Ȱµ¿À¸·Î Çõ½ÅÀûÀÎ Ä¡·á¹ýÀÌ µµÀԵǾî Áö·ç¼º °¢È­Áõ Ä¡·á ½ÃÀå ÀüüÀÇ ¼ºÀå ±Ëµµ¸¦ °­È­ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

Á¶»ç ´ë»ó ±â¾÷ÀÇ ¿¹(ÃÑ 86°Ç)

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå °³¿ä

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

KSA
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Seborrheic Keratosis Treatment Market to Reach US$3.3 Billion by 2030

The global market for Seborrheic Keratosis Treatment estimated at US$2.3 Billion in the year 2023, is expected to reach US$3.3 Billion by 2030, growing at a CAGR of 5.2% over the analysis period 2023-2030. Cryotherapy Application, one of the segments analyzed in the report, is expected to record a 6.2% CAGR and reach US$2.0 Billion by the end of the analysis period. Growth in the Electrocautery Application segment is estimated at 4.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$635.6 Million While China is Forecast to Grow at 8.7% CAGR

The Seborrheic Keratosis Treatment market in the U.S. is estimated at US$635.6 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$701.8 Million by the year 2030 trailing a CAGR of 8.7% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.0% and 5.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.2% CAGR.

Global Seborrheic Keratosis Treatment Market - Key Drivers and Trends Summarized

Seborrheic keratosis is a common, non-cancerous skin growth that typically appears as a brown, black, or light tan growth on the face, chest, shoulders, or back. These growths are usually painless and require no treatment unless they become irritated or for cosmetic reasons. Treatments for seborrheic keratosis include cryotherapy, curettage, electrosurgery, and laser therapy. These methods aim to remove or reduce the appearance of the growths, providing relief and enhancing the patient's skin aesthetics. The choice of treatment depends on the size, number, and location of the growths, as well as patient preference and healthcare provider recommendations.

Technological advancements in the medical field have significantly impacted the seborrheic keratosis treatment market. Cryotherapy, which involves freezing the growth with liquid nitrogen, is a widely used technique due to its effectiveness and minimal recovery time. Curettage involves scraping off the growth under local anesthesia, often combined with electrosurgery, where an electric current is used to destroy the growth. Laser therapy, utilizing focused light to target and remove the growth, has gained popularity for its precision and minimal scarring. The development of new laser technologies, such as fractional lasers, has improved treatment outcomes, making the process quicker and less painful. Additionally, the advent of topical treatments that can be applied at home offers a non-invasive alternative for managing smaller growths, expanding the range of options available to patients.

The growth in the seborrheic keratosis treatment market is driven by several factors. Increasing awareness about skin health and the availability of advanced dermatological treatments has spurred demand. The aging population, who are more prone to developing seborrheic keratosis, significantly contributes to market growth. Additionally, rising disposable incomes enable more individuals to opt for cosmetic procedures. Technological advancements, such as the development of more effective and less invasive treatment methods, have also propelled the market forward. Consumer behavior trends indicate a growing preference for non-invasive and outpatient procedures, which are more convenient and have shorter recovery times. The expansion of dermatology clinics and the increasing presence of skilled dermatologists further support market growth. Moreover, continuous research and development activities in the field are expected to introduce innovative treatments, enhancing the overall growth trajectory of the seborrheic keratosis treatment market.

Select Competitors (Total 86 Featured) -

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â